Drug Cos. Hit Back In High Court 'Blocking Patent' Fight
A group of generic-drug makers pushed the U.S. Supreme Court on Friday to uphold the so-called "blocking patent" doctrine that was used to strike down multiple Acorda Therapeutics patents for multiple...To view the full article, register now.
Already a subscriber? Click here to view full article